Annual Short Term Debt
$1.48 M
-$351.00 K-19.16%
31 December 2023
Summary:
Prelude Therapeutics Incorporated annual short term debt is currently $1.48 million, with the most recent change of -$351.00 thousand (-19.16%) on 31 December 2023. During the last 3 years, it has risen by +$1.48 million (+100.00%). PRLD annual short term debt is now -19.16% below its all-time high of $1.83 million, reached on 31 December 2022.PRLD Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.72 M
-$15.00 K-0.55%
30 September 2024
Summary:
Prelude Therapeutics Incorporated quarterly short term debt is currently $2.72 million, with the most recent change of -$15.00 thousand (-0.55%) on 30 September 2024. Over the past year, it has increased by +$2.25 million (+473.47%). PRLD quarterly short term debt is now -0.55% below its all-time high of $2.74 million, reached on 30 June 2024.PRLD Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRLD Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.2% | +473.5% |
| 3 y3 years | +100.0% | +48.4% |
| 5 y5 years | +100.0% | - |
PRLD Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -19.2% | -0.6% | +473.5% | |
| 5 y | 5 years | -19.2% | -0.6% | ||
| alltime | all time | -19.2% | -0.6% |
Prelude Therapeutics Incorporated Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.72 M(-0.5%) |
| June 2024 | - | $2.74 M(+25.2%) |
| Mar 2024 | - | $2.19 M(+47.7%) |
| Dec 2023 | $1.48 M(-19.2%) | $1.48 M(+211.8%) |
| Sept 2023 | - | $475.00 K(-49.4%) |
| June 2023 | - | $938.00 K(-32.5%) |
| Mar 2023 | - | $1.39 M(-24.1%) |
| Dec 2022 | $1.83 M | $1.83 M(+32.0%) |
| Sept 2022 | - | $1.39 M(-23.8%) |
| June 2022 | - | $1.82 M(-2.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.86 M(+6.8%) |
| Dec 2021 | $1.74 M(>+9900.0%) | $1.74 M(-5.2%) |
| Sept 2021 | - | $1.84 M(+30.9%) |
| June 2021 | - | $1.40 M(0.0%) |
| Mar 2021 | - | $1.40 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2020 | - | $0.00(-100.0%) |
| June 2020 | - | $67.00 K(-74.0%) |
| Dec 2019 | $258.00 K(>+9900.0%) | $258.00 K |
| Dec 2018 | $0.00 | - |
FAQ
- What is Prelude Therapeutics Incorporated annual short term debt?
- What is the all time high annual short term debt for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual short term debt year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly short term debt?
- What is the all time high quarterly short term debt for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly short term debt year-on-year change?
What is Prelude Therapeutics Incorporated annual short term debt?
The current annual short term debt of PRLD is $1.48 M
What is the all time high annual short term debt for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual short term debt is $1.83 M
What is Prelude Therapeutics Incorporated annual short term debt year-on-year change?
Over the past year, PRLD annual short term debt has changed by -$351.00 K (-19.16%)
What is Prelude Therapeutics Incorporated quarterly short term debt?
The current quarterly short term debt of PRLD is $2.72 M
What is the all time high quarterly short term debt for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly short term debt is $2.74 M
What is Prelude Therapeutics Incorporated quarterly short term debt year-on-year change?
Over the past year, PRLD quarterly short term debt has changed by +$2.25 M (+473.47%)